Upgrade to SI Premium - Free Trial

Stifel Reiterates Buy Rating on Mirum Pharmaceuticals (MIRM)

September 28, 2026 9:33 AM
Stifel analyst James Condulis reiterated a Buy ...

(Premium-only article. Please sign in or upgrade to SI Premium to view.)

Categories

Analyst Comments